Bellerophon Therapeutics, Inc. BLPH Income Statement

Bellerophon therapeutics, inc. (BLPH)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14
Operating expenses:
Research and development
10,965	11,032	11,010	12,998	16,184	20,259	22,832	22,023	20,897	17,854	17,575	15,609	14,874	16,650	19,868	24,486	28,958	33,365	34,646	39,115	43,458	45,978	0	0	0
General and administrative
6,276	6,441	6,832	7,084	7,546	7,621	7,673	7,835	7,411	6,745	7,007	7,006	6,577	7,107	7,459	10,043	12,273	14,870	15,514	15,119	15,878	13,775	0	0	0
Total operating expenses
17,241	17,473	17,842	20,082	23,730	27,880	30,505	29,858	28,308	24,599	24,582	22,615	21,451	23,757	27,327	34,529	41,231	48,235	50,160	54,234	59,336	59,753	0	0	0
Other operating income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,667	1,667	1,417	1,166	0	0	0	0
Loss from operations
-17,241	-17,473	-17,842	-20,082	-23,730	-27,880	-30,505	-29,858	-28,308	-24,599	-24,582	-22,615	-21,451	-23,757	-27,327	-34,279	-40,730	-46,568	-48,493	-52,817	-58,170	-59,753	0	0	0
Change in fair value of common stock warrant liability
-172	-2,682	-6,180	-23,805	-19,443	-24,877	-4,253	15,022	8,966	30,403	14,045	12,610	14,977	590	0	0	0	0	0	0	0	-	-	-	-
Warrant amendment charge
-	674	674	674	-	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest and other income, net
301	397	436	439	409	378	380	321	256	184	107	96	92	95	110	115	120	109	91	77	98	79	0	0	0
Pre-tax loss
-17,442	-15,068	-11,900	3,488	-3,878	-2,625	-25,872	-44,559	-37,018	-54,818	-38,520	-35,129	-36,336	-24,252	-27,217	-34,164	-40,610	-46,459	-48,402	-52,740	-58,072	-59,674	0	0	0
Income tax benefit
0	-1,801	-1,801	-1,801	-1,801	-5,439	-5,439	-5,439	-5,439	0	-438	-438	-438	-438	0	0	0	0	0	0	0	0	0	0	0
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-46,459	-48,402	-52,740	-58,072	-59,674	0	0	0
Net loss
-17,442	-13,267	0	0	0	-	-	-	-	-	-	-	-	-23,814	0	0	0	-	-	-	-	-	-	-	-
Weighted average shares outstanding:
Basic (in shares)
4,615	4,566	4,553	4,543	4,346	3,847	3,847	3,815	3,803	55,109	34,989	33,558	31,934	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in shares)
4,615	4,566	4,553	4,543	4,346	3,971	4,302	3,815	4,806	55,109	34,989	40,491	31,934	-	-	-	-	-	-	-	-	-	-	-	-
Basic and diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	20,186	13,854	13,093	13,053	13,026	12,911	12,910	10,152	7,898	7,897	7,898	7,899
Net loss per share:
Basic (in usd per share)
-1.08	-0.89	-0.94	-0.90	-0.18	-0.24	2.89	-3.01	1.08	-0.44	-0.22	-0.12	-0.60	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in usd per share)
-1.08	-0.89	-0.94	-0.90	-0.18	-1.15	-1.55	-3.01	-0.60	-0.44	-0.22	-0.15	-0.60	-	-	-	-	-	-	-	-	-	-	-	-
Basic and diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-0.37	-0.30	-0.39	-0.54	-0.83	-0.86	-0.90	-1.27	-1.62	-1.96	-2.14	-1.84